SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Meta Platforms, Inc. engages in the development of social media applications. It builds technology that helps people connect and share, find communities, and grow businesses. It operates through the Family of Apps (FoA) and Reality Labs (RL) segments. The FoA segment consists of Facebook, Instagram, Messenger, WhatsApp, and other services. The RL segment includes augmented, mixed and virtual reality related consumer hardware, software, and content. The company was founded by Mark Elliot Zuckerberg, Dustin Moskovitz, Chris R. Hughes, Andrew McCollum, and Eduardo P. Saverin on February 4, 2004, and is headquartered in Menlo Park, CA.

Meta Platforms Inc - Ordinary Shares - Class A

Meta Platforms Inc

Meta shares are experiencing volatility following the launch of Muse, a personal AI agent that performs tasks across apps. Traders are debating whether this product demonstrates meaningful vertical integration or if it serves as a reaction to cooling investor sentiment regarding the company's massive AI capital spending.

Apple, Inc. engages in the design, manufacture, and sale of smartphones, personal computers, tablets, wearables and accessories, and other varieties of related services. It operates through the following geographical segments: Americas, Europe, Greater China, Japan, and Rest of Asia Pacific. The Americas segment includes North and South America. The Europe segment consists of European countries, as well as India, the Middle East, and Africa. The Greater China segment comprises China, Hong Kong, and Taiwan. The Rest of Asia Pacific segment includes Australia and Asian countries. Its products and services include iPhone, Mac, iPad, AirPods, Apple TV, Apple Watch, Beats products, AppleCare, iCloud, digital content stores, streaming, and licensing services. The company was founded by Steven Paul Jobs, Ronald Gerald Wayne, and Stephen G. Wozniak in April 1976 and is headquartered in Cupertino, CA.

Apple Inc

Apple shares are trending amid anticipation for the upcoming product launch event, where the company is widely expected to unveil its first foldable iPhone. While some traders are bullish on a potential 'event run-up' and the company's long-term growth, others remain skeptical, citing reports of limited initial production capacity and a 'sell the news' pattern often observed during major announcements.

BioCryst Pharmaceuticals, Inc. is a biotechnology company. It engages in the provision of structure-guided drug design with the goal of developing oral small-molecule and protein therapeutics to target difficult-to-treat rare diseases. The company was founded by William M. Spencer III, Charles E. Bugg, and John A. Montgomery in 1986 and is headquartered in Durham, NC.

Biocryst Pharmaceuticals Inc.

BioCryst shares experienced a sharp decline following positive Phase 3 clinical trial data from Pharvaris, which investors fear could create a stronger oral competitor to BioCryst's leading drug, Orladeyo. While some traders view the drop as an overreaction, noting the long timeline before any potential competition reaches the market and the strength of the company's existing commercial infrastructure, others express frustration with the stock's volatility and the lack of a near-term buyout catalyst.

Zcash is a privacy-focused cryptocurrency that uses trustless zero-knowledge proofs to enable fully encrypted transactions while maintaining blockchain transparency and security. It was the first cryptocurrency to implement zero-knowledge encryption for private peer-to-peer payments, addressing the fundamental privacy gap in traditional cryptocurrencies that expose transaction details publicly.   With a fixed supply of 21 million ZEC and a halving schedule similar to Bitcoin, Zcash allows users to prove transactions are valid without revealing sensitive information like wallet balances, transaction amounts, or participant identities, making it suitable for everyday payments, long-term savings, and cross-border money transfers where financial confidentiality matters.  The protocol operates on its own blockchain currently using Proof-of-Work consensus, though it's evolving toward Proof-of-Stake through the planned "Crosslink" upgrade to enhance security, scalability, and energy efficiency. Zcash employs trustless zero-knowledge proofs (Halo) within its Orchard shielded pool to verify transactions without revealing sender, receiver, or amount information.   Users can choose between transparent public transactions and shielded private transactions through Unified Addresses, which work with both types. The network is faster and cheaper than Bitcoin, with new blocks mined every 75 seconds and transaction fees typically just a fraction of a cent. Privacy adoption has surged in 2025, with over 30% of total ZEC supply now held in fully shielded pools.  Zcash was created by a group of scientists in 2013 who initially proposed Zerocoin as a privacy extension to Bitcoin before building a standalone protocol. The ecosystem operates with a self-funded development model where block rewards support independent teams through the Zcash Community Grants Committee and a new Coinholder-Controlled Fund.

Zcash

Zcash is surging amid extreme bullish sentiment, with traders highlighting its privacy features, limited supply, and potential to challenge Bitcoin’s market position. The asset is also benefiting from a massive short squeeze, as heavily leveraged positions are being liquidated, fueling further upside momentum.

Rigetti Computing, Inc. provides full-stack quantum computing services. It serves global enterprise, government, and research clients through its Rigetti Quantum Cloud Services platform. The company was founded by Chad Rigetti in 2013 and is headquartered in Berkeley, CA.

Rigetti Computing Inc

Rigetti Computing is trending as traders react to a finalized $100 million U.S. government funding agreement under the CHIPS Act. While the news is driving market momentum, the community is divided by intense debates over stock dilution from the government's equity stake and skepticism regarding the company's path to commercial profitability.

Zscaler, Inc. engages in the provision of a cloud-based internet security platform. It offers Zero Trust Exchange, Zscaler Client Connector, Zscaler Internet Access, Zscaler Private Access, Zscaler B2B, Zscaler Cloud Protection, and Zscaler Digital Experience. The company was founded by Jagtar Singh Chaudhry and K. Kailash in September 2007 and is headquartered in San Jose, CA.

Zscaler Inc

Zscaler is experiencing volatility as the market debates its valuation and growth trajectory following its fiscal fourth-quarter results, with investor sentiment split between concerns over decelerating revenue growth and optimism surrounding its new AI-driven security platform and strong recurring revenue metrics. While the stock has faced downward pressure, numerous analysts have reiterated bullish stances, citing the company's long-term potential in the zero-trust and AI-security market.

Schwab Strategic Trust - Schwab US Dividend Equity ETF

Schwab US Dividend Equity ETF

SCHD is trending as investors favor it as a defensive anchor for their portfolios amid tech market volatility and speculative AI concerns. The conversation is largely characterized by a long-term, buy-and-hold strategy, with community members emphasizing its role in stable dividend growth and wealth compounding despite recent price fluctuations.

AstraZeneca Plc is a global, science-led biopharmaceutical company focused on the discovery, development, and commercialization of prescription medicines. Its portfolio spans oncology, rare diseases, and biopharmaceuticals, including cardiovascular, renal & metabolism, and respiratory & immunology. The company was founded in 1913 and is headquartered in Cambridge, the United Kingdom.

Astrazeneca plc

AstraZeneca PLC

AstraZeneca's stock is trending following the company's recent investor day updates, where leadership reiterated an $80 billion revenue target for 2030 supported by a robust oncology pipeline and anticipated late-stage clinical readouts. Community discussion reflects a mix of optimism regarding its growth strategy and ongoing debates about the company's competitive position in the obesity and rare disease markets.

Magnite, Inc. provides a technology solution to automate the purchase and sale of digital advertising inventory for buyers and sellers. It features applications and services for digital advertising sellers including websites, mobile applications, and other digital media properties. The company was founded by Frank Addante, Duc Chau, Craig Roah, Julie Mattern and Brian D. Baumgart on April 20, 2007 and is headquartered in New York, NY.

Magnite Inc

Magnite is trending as investors respond to strong quarterly earnings, improved guidance, and the company's positioning as essential infrastructure for Connected TV (CTV) and agentic advertising. Discussion remains focused on the potential for long-term gains driven by CTV growth, market share expansion, and ongoing anticipation regarding court-ordered remedies in the Google ad-tech antitrust litigation.

Nokia Oyj engages in the provision of network infrastructure, technology, and software services. It operates through the following segments: Mobile Networks, Network Infrastructure, Cloud and Network Services, and Nokia Technologies. The Mobile Networks segment offers technologies for Radio Access Networks (RAN) as well as Microwave Radio Links (MWR) for transport networks. The Network Infrastructure serves communication service providers, enterprises, webscales and public sector customers. The Cloud and Network Services segment builds around software and the cloud and is focused on driving leadership in cloud-native software and as-a-service delivery models, as demand for critical networks accelerates; and with strong market positions in communications software, private wireless networks, and cognitive (or intelligent) services. The Nokia Technologies segment, building on decades of innovation and R&D leadership in technologies used in virtually all mobile devices used today, is expanding the Nokia patent licensing business, reintroducing the Nokia brand to smartphones through brand licensing, and establishing a technology licensing business. The company was founded by Fredrik Idestam in 1865 and is headquartered in Espoo, Finland.

Nokia Corp - ADR

Nokia Corp

Nokia is trending following speculation regarding potential U.S. government investment and strategic alignment, spurred by a visit from the U.S. International Development Finance Corporation CEO to Nokia's Finnish headquarters. Traders are also closely monitoring the company's planned withdrawal from China and its positioning within the AI and 5G infrastructure sector.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$ELUT This has been a disaster of a stock story. Selling a high valued product such as ELUPRO at peanuts and now getting lowballed with SimpliDerm which made $12 million couple of years ago. The investors have lost confidence in the BOD and hence no funding or investment is forthcoming. The stock is lagging behind because of the management weakness and not in the science. Regenerative stocks are touted as the next big thing in Biotech and this stock is unable to ride the wave. It is better be sold to a large pharma who can unlock the value of this technology in myriad ways and monetize it better.

StockTwits Web

Elutia Inc - Ordinary Shares - Class A

 This has been a disaster of a stock story. Selling a high valued product such as ELUPRO at peanuts and now getting lowballed with SimpliDerm which made $12 million couple of years ago. The investors have lost confidence in the BOD and hence no funding or investment is forthcoming. The stock is lagging behind because of the management weakness and not in the science. Regenerative stocks are touted as the next big thing in Biotech and this stock is unable to ride the wave. It is better be sold to a large pharma who can unlock the value of this technology in myriad ways and monetize it better.